FROHLICH TOM (Chief Business Officer) sold 2.4% of their position (3.70K shares) of CHINOOK THERAPEUTICS, INC. on the open market
Open‑market sale worth $87.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/15/2023ACC: 0001209191-23-009769
Officer· Chief Business Officer
Since Oct 2020
-3.70K
Net shares
Net seller
$87.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.80K acquired · 10.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.80K
Price / share
—
Trade value
—
% of position
4.6%
2/10/2023
147.67K→154.48K
Common Stock
Direct
Shares
−3.70K
Price / share
$23.75
Trade value
$87.87K
% of position
2.4%
2/10/2023
154.48K→150.78K
Total
Net shares
+3.10K
Net value
-$87.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2023 | M · Option Exercise | +6.80K | — | — | 4.6% | 147.67K | 154.48K |
| Common Stock Direct | 2/10/2023 | S · Sale | −3.70K | $23.75 | $87.87K | 2.4% | 154.48K | 150.78K |
| Total | +3.10K | -$87.87K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.80K shares
Shares
−6.80K
Strike price
Held after
6.80K
Exercisable
—
2/10/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.80K shares | 2/10/2023 | M · Option Exercise | −6.80K | — | 6.80K |